Match ends, Ajax 3, Shelbourne 1. Attempt missed. Anton Gaaei (Ajax) right footed shot from the centre of the box misses to the right. Assisted by Oliver Edvardsen with a cross. Attempt missed. Marcos ...
Ajax host Shelbourne at the Johan Cruijff ArenA on Thursday in the first leg of their UEFA Conference League third qualifying round tie. The Dutch giants head into the match full of confidence after ...
Ajax face Shelbourne FC on Thursday evening in the third qualifying round of the Conference League. Kick-off at the sold-out Johan Cruijff ArenA is at 20:00 and the match can be followed live on ...
Pre-season is drawing to a close, the first competitive matches have been played and the transfer market is in full swing. The new Eredivisie season is now just around the corner. In a series of ...
Sobeys on Kingston Road in Ajax will close this summer and a new grocery store within the same company will open in its place in 2027. “We are always reviewing our assets and offerings to meet the ...
IHOP is finally coming to Ajax and it’s set to open this summer. It has been three years since a “coming soon” sign was posted at a different location in Ajax and stirred excitement among local ...
Ajax Therapeutics is among about 10 publicly-announced acquisitions by Eli Lilly so far this year. (Angus Liu/Fierce Pharma) Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing ...
LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with strict controls ...
Eli Lilly LLY-0.39%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...
Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...
April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results